About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Pennsylvania | 30,724 Studies Near You

Clinical TrialsPennsylvania

Clinical Trials in Pennsylvania

Discover 30,724 clinical trials near Pennsylvania. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 101-120 of 30,724 trials

CompletedNudging High-acuity Emergency Department Patients to Schedule a Follow-up VisitThe goal of this campaign is to reduce unnecessary emergency department (ED) visits by encouraging patients with high acuity visits to follow up with an appropriate primary care…NCT06535347·Danville, Pennsylvania CompletedCompare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical MedicationsThis is a single-blind (blinded expert grader) study that will enroll 25-30 healthy volunteers without facial acne.NCT01015638·Broomall, Pennsylvania CompletedS0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone SurgeryRATIONALE: Everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth or by blocking blood flow to the tumor.NCT01120249·Birmingham, Alabama and 1002 others

Find Trials by Condition in Pennsylvania

Breast Cancerin Pennsylvania Lung Cancerin Pennsylvania Prostate Cancerin Pennsylvania Colorectal Cancerin Pennsylvania Melanomain Pennsylvania Leukemiain Pennsylvania Lymphomain Pennsylvania Pancreatic Cancerin Pennsylvania Ovarian Cancerin Pennsylvania Brain Cancerin Pennsylvania

Data from ClinicalTrials.govTerms

TerminatedClinical Prediction Rule for Clinical Lumbar InstabilityThe aim of this study is to determine if assessment of additional measures of trunk neuromuscular control will improve the ability to identify patients with low back pain who…NCT01085448·Philadelphia, Pennsylvania and 1 other

WithdrawnIntensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC VaccinesThis study will evaluate the immunologic and potential clinical effectiveness of intensive locoregional sequential intraperitoneal (IP) cisplatin (IPC) with intravenous (iv)…NCT02432378·Pittsburgh, Pennsylvania and 1 other

CompletedA Study to Demonstrate the Benefit of a New Kind of Anti-cancer Treatment [PReferentially Expressed Antigen of MElanoma (PRAME) Immunotherapy] for Patients With Non-Small Cell Lung Cancer (NSCLC), After Removal of Their TumorThe purpose of this study was to test a potential new kind of anti-cancer treatment, called PRAME immunotherapy in resected patients with lung cancer.NCT01853878·Newark, Delaware and 38 others

RecruitingWindow of Opportunity in Preserving Laryngeal Function TrialThis trial will study the safety and tolerability and disease survival rates in adult patients with recurrent/metastatic (R/M) HNSCC when treated with carboplatin or cisplatin…NCT07423078·Pittsburgh, Pennsylvania

RecruitingPPMI Clinical - Establishing a Deeply Phenotyped PD CohortThe Parkinson Progression Marker Initiative (PPMI) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital…NCT04477785·Birmingham, Alabama and 49 others

CompletedA Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular RosaceaThe primary objective is to show that open-label extended treatment with FMX103 1.5%, for up to an additional 40 weeks, is safe and well tolerated.NCT03276936·Glendale, Arizona and 78 others

RecruitingA Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid TumorsThis is a two-part Phase 1, open label, multi-center, single arm, non-randomized, multiple dose, safety, pharmacokinetic (PK) and preliminary efficacy study of single agent…NCT06326411·San Francisco, California and 22 others

CompletedAntidepressant Medication Plus Donepezil for Treating Late-life DepressionThis study will determine the effectiveness of combining escitalopram, venlafaxine, or duloxetine with donepezil, a medication used in Alzheimer's disease, in improving memory…NCT00177671·Pittsburgh, Pennsylvania

CompletedPromoting Stress Management and Engagement in Introductory Physics Courses with Mindfulness and RelaxationThis study tests the impact of mindfulness vs. relaxation training on psychological threat and challenge, emotions/emotion regulation, motivation/engagement, and performance among…NCT05542498·Pittsburgh, Pennsylvania

CompletedStudy Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)This is an open-label, randomized trial in relapsed refractory subjects with mantle cell lymphoma (MCL).NCT00117598·Little Rock, Arkansas and 72 others

CompletedA Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive DisorderThe purpose of this study is to assess the effect and safety of AZD6765 in patients with major depressive disorder who exhibit inadequate response to antidepressants.NCT01482221·Chino, California and 43 others

Active not recruitingAutus Valve Pivotal StudyProspective, single-arm, multi-center study to evaluate safety and effectiveness of the Autus Size-Adjustable Valve in pediatric patients aged 18 months to 16 years requiring…NCT05006404·Los Angeles, California and 11 others

CompletedINSPIRE Continuation Post-Approval StudyTo evaluate long-term BOS-free survival outcomes of the OCS™ Lung INSPIRE Trial patients.NCT03868904·Phoenix, Arizona and 16 others

CompletedCOL-3 in Treating Patients With Progressive or Recurrent Brain TumorsRATIONALE: COL-3 may stop the growth of brain tumors by stopping blood flow to the tumor.NCT00004147·Birmingham, Alabama and 8 others

TerminatedAn Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus NephritisThe purpose of this study is to evaluate the safety and effectiveness of BMS-986165 compared with placebo with regard to measures of kidney function in participants with lupus…NCT03943147·Birmingham, Alabama and 99 others

CompletedAntigen-Specific Cell Mediated Immune Response to Chlamydia TrachomatisThis is an exploratory study in which the investigators will develop a way to identify the cell responses most strongly associated with protection against chlamydia infection.NCT00970749·Pittsburgh, Pennsylvania

Active not recruitingTrial Combining Pembrolizumab and Cesium 131 Brachytherapy With Salvage Surgery in HNSCCTo Study Perioperative PD-1 Inhibitor and Cesium-131 Interstitial Brachytherapy in patients with locally recurrent HNSCC eligible for salvage surgery.NCT04340258·Cincinnati, Ohio and 1 other

PreviousPage 6 of 1537Next

Diabetes

in Pennsylvania

Heart Diseasein Pennsylvania